Cargando…
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
Head and neck squamous cell carcinoma (HNSCC) is a common cancer diagnosis worldwide. Despite advances in treatment, HNSCC has very poor survival outcomes, emphasizing an ongoing need for development of improved therapeutic options. The distinct tumor characteristics of human papillomavirus (HPV)-po...
Autores principales: | Ghasemi, Farhad, Black, Morgan, Sun, Ren X., Vizeacoumar, Frederick, Pinto, Nicole, Ruicci, Kara M., Yoo, John, Fung, Kevin, MacNeil, Danielle, Palma, David A., Winquist, Eric, Mymryk, Joe S., Ailles, Laurie A., Datti, Alessandro, Barrett, John W., Boutros, Paul C., Nichols, Anthony C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5995257/ https://www.ncbi.nlm.nih.gov/pubmed/29899842 http://dx.doi.org/10.18632/oncotarget.25436 |
Ejemplares similares
-
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
por: Ghasemi, Farhad, et al.
Publicado: (2017) -
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models
por: Pinto, Nicole, et al.
Publicado: (2020) -
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
por: Ruicci, Kara M., et al.
Publicado: (2020) -
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
por: Mundi, Neil, et al.
Publicado: (2019) -
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
por: Pinto, Nicole, et al.
Publicado: (2018)